Neovasc Inc. (NVCN)

NASDAQ: NVCN · IEX Real-Time Price · USD
29.88
+0.46 (1.56%)
At close: Mar 24, 2023, 4:00 PM
29.41
-0.47 (-1.57%)
After-hours: Mar 24, 2023, 5:32 PM EDT
1.56%
Market Cap 82.45M
Revenue (ttm) 3.11M
Net Income (ttm) -33.52M
Shares Out 2.76M
EPS (ttm) -12.29
PE Ratio n/a
Forward PE n/a
Dividend n/a
Ex-Dividend Date n/a
Volume 46,864
Open 29.41
Previous Close 29.42
Day's Range 29.40 - 29.89
52-Week Range 4.59 - 29.88
Beta 2.01
Analysts Buy
Price Target n/a
Earnings Date May 10, 2023

About NVCN

Neovasc Inc., a specialty medical device company, develops, manufactures, and markets products for cardiovascular marketplace in Europe and internationally. Its products include the Tiara technology for the transcatheter treatment of mitral valve disease; and the Neovasc Reducer for the treatment of refractory angina. The company was formerly known as Medical Ventures Corp. and changed its name to Neovasc Inc. in July 2008. Neovasc Inc. was incorporated in 2000 and is headquartered in Richmond, Canada. [Read more]

Industry Medical Devices
Sector Healthcare
CEO Fred Colen
Employees 49
Stock Exchange NASDAQ
Ticker Symbol NVCN
Full Company Profile

Financial Performance

In 2021, Neovasc's revenue was $2.55 million, an increase of 30.14% compared to the previous year's $1.96 million. Losses were -$24.89 million, -13.26% less than in 2020.

Financial Statements

News

Neovasc Shareholders Approve Acquisition by Shockwave Medical

Vancouver, British Columbia--(Newsfile Corp. - March 6, 2023) - Neovasc Inc. (NASDAQ: NVCN) (TSX: NVCN) ("Neovasc" or the "Company"), a leader in the development of minimally invasive devices for the ...

2 weeks ago - Newsfile Corp

Neovasc Announces German Reimbursement Renewal

Vancouver, British Columbia and Minneapolis, Minnesota--(Newsfile Corp. - February 1, 2023) - Neovasc, Inc. (NASDAQ : NVCN) (TSX : NVCN) ("Neovasc" or "the Company") today announced the German Institu...

1 month ago - Newsfile Corp

Mergers and Acquisitions in 2023 Off To A Strong Start

Mergers and acquisitions are a normal part of business, but 2023 has already presented many opportunities across the biotech industry. The M&A surge seems to be driven by two major transactions: the $...

2 months ago - MarketBeat

Shockwave Medical to Acquire Neovasc

Vancouver, British Columbia--(Newsfile Corp. - January 17, 2023) - Neovasc Inc. (NASDAQ: NVCN) (TSX: NVCN) ("Neovasc" or the "Company"), a leader in the development of minimally invasive devices for t...

Other symbols: SWAV
2 months ago - Newsfile Corp

Neovasc (NVCN) is on the Move, Here's Why the Trend Could be Sustainable

Neovasc (NVCN) made it through our "Recent Price Strength" screen and could be a great choice for investors looking to make a profit from stocks that are currently on the move.

2 months ago - Zacks Investment Research

Recent Price Trend in Neovasc (NVCN) is Your Friend, Here's Why

Neovasc (NVCN) could be a great choice for investors looking to make a profit from fundamentally strong stocks that are currently on the move. It is one of the several stocks that made it through our ...

3 months ago - Zacks Investment Research

3 Medical Instruments Stocks on Recovery Path After Dismal 2022

Here we discuss three medical instruments stocks - TCMD, VCYT and NVCN - that have started to recover in the past few months after declining for the major part of 2022.

Other symbols: TCMDVCYT
3 months ago - Zacks Investment Research

Neovasc Announces Progress on COSIRA-II Clinical Trial

Vancouver, British Columbia and Minneapolis, Minnesota--(Newsfile Corp. - November 28, 2022) - Neovasc Inc. (NASDAQ: NVCN) (TSX: NVCN) ("Neovasc" or the "Company") today announced an update on the COS...

4 months ago - Newsfile Corp

Neovasc Comments on European Heart Journal Publication

VANCOUVER and MINNEAPOLIS, Nov. 18, 2022 (GLOBE NEWSWIRE) -- via NewMediaWire – Neovasc Inc. (“Neovasc” or the “Company”) (NASDAQ, TSX: NVCN) today announced that European Heart Journal - Case Reports...

4 months ago - GlobeNewsWire

Neovasc (NVCN) Reports Q3 Loss, Misses Revenue Estimates

Neovasc (NVCN) delivered earnings and revenue surprises of -6.38% and 7.70%, respectively, for the quarter ended September 2022. Do the numbers hold clues to what lies ahead for the stock?

4 months ago - Zacks Investment Research

Neovasc Announces Third Quarter Financial Results and Provides Corporate Update

Vancouver, British Columbia and Minneapolis, Minnesota--(Newsfile Corp. - November 10, 2022) - Neovasc Inc. (NASDAQ: NVCN) (TSX: NVCN) ("Neovasc" or the "Company") today reported financial results for...

4 months ago - Newsfile Corp

Neovasc Reducer Obtains U.S. Outpatient Reimbursement

VANCOUVER and MINNEAPOLIS, Nov. 08, 2022 (GLOBE NEWSWIRE) -- via NewMediaWire -- Neovasc  Inc. (“Neovasc” or the “Company”) ( NASDAQ ,  TSX : NVCN) today announced that the Centers for Medicare and Me...

4 months ago - GlobeNewsWire

Neovasc to Report Third Quarter Financial Results on November 10, 2022

Vancouver, British Columbia and Minneapolis, Minnesota--(Newsfile Corp. - October 27, 2022) - Neovasc Inc. (NASDAQ: NVCN) (TSX: NVCN) will report financial results for the quarter ended September 30, ...

5 months ago - Newsfile Corp

Neovasc Provides Corporate Update Following Clinical Data Release

New Data Presented on the Neovasc Reducer™ in Patients With Microvascular Disease

6 months ago - GlobeNewsWire

Neovasc to Participate in LSI Europe 2022 Emerging MedTech Summit

VANCOUVER and MINNEAPOLIS, Sept. 16, 2022 (GLOBE NEWSWIRE) -- via NewMediaWire -- Neovasc, Inc.  (Neovasc or the Company) (  NASDAQ  ,  TSX  : NVCN) today announced that its management team will be pa...

6 months ago - GlobeNewsWire

Neovasc Comments on New ICD-10-CM Diagnosis Codes for Refractory Angina

VANCOUVER and MINNEAPOLIS, Sept. 15, 2022 (GLOBE NEWSWIRE) -- via NewMediaWire – Neovasc Inc. (“Neovasc” or the “Company”) (NASDAQ, TSX: NVCN) today commented on the Centers for Medicare and Medicaid ...

6 months ago - GlobeNewsWire

Neovasc Announces Key Events at TCT 2022

VANCOUVER and MINNEAPOLIS, Sept. 08, 2022 (GLOBE NEWSWIRE) -- via NewMediaWire – Neovasc Inc. (“Neovasc” or the “Company”) (NASDAQ, TSX: NVCN) today announced its participation and presence at the Tra...

7 months ago - GlobeNewsWire

Neovasc to Participate in H.C. Wainwright 24th Annual Global Investment Conference

Vancouver, British Columbia and Minneapolis, Minnesota--(Newsfile Corp. - August 30, 2022) - Neovasc, Inc. (Neovasc or the Company) (NASDAQ: NVCN) (TSX: NVCN) today announced that its management team ...

7 months ago - Newsfile Corp

Neovasc Announces Second Quarter Financial Results and Provides Corporate Update

Vancouver, British Columbia and Minneapolis, Minnesota--(Newsfile Corp. - August 11, 2022) - Neovasc Inc. (NASDAQ: NVCN) (TSX: NVCN) ("Neovasc" or the "Company") today reported financial results for t...

8 months ago - Newsfile Corp

Neovasc to Report Second Quarter Financial Results on August 11, 2022

Vancouver, British Columbia and Minneapolis, Minnesota--(Newsfile Corp. - July 28, 2022) - Neovasc Inc. (NASDAQ: NVCN) (TSX: NVCN), will report financial results for the quarter ended June 30, 2022 on...

8 months ago - Newsfile Corp

Neovasc Announces FDA Approval of Planned COSIRA II Sub-studies and Single Arm Registry to Allow Inclusion of Additional Specified Patient Populations

VANCOUVER and MINNEAPOLIS, July 26, 2022 (GLOBE NEWSWIRE) -- via NewMediaWire – Neovasc, Inc. ("Neovasc" or the "Company") (NASDAQ, TSX: NVCN) today announced the United States Food and Drug Administr...

8 months ago - GlobeNewsWire

Neovasc Announces Direct Sales Operations in United Kingdom

Expansion Driven by NICE Guidelines and Enhanced Reimbursement for the Neovasc Reducer™

9 months ago - GlobeNewsWire

Neovasc to Participate in Sidoti & Co. Summer Small Cap Virtual Investor Conference

Vancouver, British Columbia and Minneapolis, Minnesota--(Newsfile Corp. - June 8, 2022) - Neovasc, Inc. (NASDAQ: NVCN) (TSX: NVCN) (Neovasc or the Company) today announced that its management team wil...

10 months ago - Newsfile Corp

Neovasc to Participate in H.C. Wainwright Global Investment Conference

VANCOUVER and MINNEAPOLIS, May 23, 2022 (GLOBE NEWSWIRE) -- via  NewMediaWire --  Neovasc, Inc.  (Neovasc or the Company) ( NASDAQ  ,  TSX  : NVCN) today announced that its management team will be par...

10 months ago - GlobeNewsWire

Neovasc Regains Compliance with Nasdaq Minimum Bid Price Rule

VANCOUVER and MINNEAPOLIS, May 16, 2022 (GLOBE NEWSWIRE) -- via NewMediaWire – Neovasc Inc. ("Neovasc" or the "Company") (NASDAQ, TSX: NVCN) announced today that it has received written notification f...

11 months ago - GlobeNewsWire